Pure Global

Test for HbA1c - India CDSCO Medical Device Registration

Test for HbA1c is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000203_8adb2dcfef0129adf6b0516c0981aba7_bd7a8ce8478bc2cf83e309d2d072a44f. This device is marketed under the brand name QDx Instacheck™ Cortisol. The license holder is DiaSys Diagnostics India Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Test for HbA1c
UID: IMP/MD/2018/000203_8adb2dcfef0129adf6b0516c0981aba7_bd7a8ce8478bc2cf83e309d2d072a44f

Brand Name

QDx Instacheck™ Cortisol

Device Class

Class B

Approving Authority

CDSCO

Product Information

QDx Instacheck™ HbA1c along with QDx Instacheck™ Reader is a fluorescence Immunoassay (QDx Instacheck™ Cortisol) for the quantitative determination of HbA1c (QDx Instacheck™ Cortisol) in human whole blood. It is useful as an aid in management and monitoring of the long-term glycemic status in patients with diabetes mellitus

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing